---
title: What an AI agent reads on Omeicos Therapeutics Gmbh · The Direct Index
url: https://directindex.org/r/omeicos.com/agent-view?format=md
---

[The Direct Index](https://directindex.org/)
[Scanner](https://directindex.org/scan)[Cities](https://directindex.org/cities)[Numbers](https://directindex.org/stats)[Rankings](https://directindex.org/rankings)[Search](https://directindex.org/search)[Guides](https://directindex.org/guides)[About](https://directindex.org/about)

 [Report](https://directindex.org/r/omeicos.com) · scanned 2026-10-17

# What an AI agent reads on Omeicos Therapeutics Gmbh

An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. This is that view of [omeicos.com](http://www.omeicos.com/), from the copy the scanner kept.

3,065

characters of text without JavaScript

none

structured data for the business

0

of 3 AI crawlers turned away at the edge

 Text

## The words an agent gets

Title: OMEICOS · language en-US. First 1,800 of 3,065 characters:

```
OMEICOS Skip to content COMPANY OVERVIEW LEADERSHIP BOARD INVESTORS TIMELINE OUR SCIENCE INTRODUCTION Mode of Action SCIENCE LIBRARY PIPELINE OVERVIEW PMD-OPTION study OMT-28 NEWS & EVENTS TEAM & CAREERS LEGAL NOTICE DISCLAIMER DATA PROTECTION HOME OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases Following Positive EOP2 Meeting with the FDA Targeting Both Inflammation and Mitochondrial Dysfunction to Address Diseases With High Unmet Need OMEICOS is focused on developing therapies that have the potential for a significant impact on cardiovascular, inflammatory and mitochondrial diseases with high unmet need. Our pipeline is based on our proprietary approach to target one of nature’s most important cell-protective pathways and industry-leading knowledge of omega-3 fatty acid metabolism and biology. Our lead compound OMT-28 has successfully concluded the Phase 2a proof-of-concept study in Primary Mitochondrial Disease (PMD). The „PMD-OPTION“ study demonstrated OMT-28’s therapeutic potential to improve the physical condition in patients with PMD based on significant recovery of the impaired mitochondrial function in the responding patients. The study also further underscored the excellent safety and tolerability profile of OMT-28, which has been evaluated in more than 190 individuals to date. Subsequently, the program has received strong endorsement from the U.S. Food and Drug Administration (FDA) in an End-of-Phase 2 (EOP2) meeting and as a result is now positioned to advance directly into a pivotal Phase 3 study. OMT-28 had previously been evaluated in a double-blinded, placebo-controlled, multi-center Phase 2 clinical trial in patients suffering from atrial fibrillation. In this study, OMT-28 demonstrated an excellent safety and tolerability profile,
```

 Facts

## What it can state about the business

| A business type in JSON-LD | no |
| Name | no |
| Telephone | no |
| Address | no |
| Opening hours | no |
| Menu or price list | nothing |
| Cuisine in structured data | no |
| JSON-LD blocks | 0 |

 Actions

## The links it would act on

No booking or ordering link found. An agent has nothing to act on.

Everything here comes from one fetch of the homepage as a crawler; the [report](https://directindex.org/r/omeicos.com) turns it into a score and fixes, with a kit to paste.

#### The Direct Index

[Why direct](https://directindex.org/why)[What agent-direct means](https://directindex.org/agent-direct)[About and principles](https://directindex.org/about)[Methodology](https://directindex.org/methodology)[Privacy](https://directindex.org/privacy)[Terms](https://directindex.org/terms)

#### Use it

[Free scanner](https://directindex.org/scan)[City indexes](https://directindex.org/cities)[Search the index](https://directindex.org/search)[Rankings](https://directindex.org/rankings)[What assistants recommend](https://directindex.org/assistants)[Ask the index](https://directindex.org/ask)

#### Vendors and help

[Booking and ordering vendors](https://directindex.org/vendors)[Do their terms allow agents?](https://directindex.org/vendors/terms)[Vendor verification](https://directindex.org/vendors/verification)[Website builders](https://directindex.org/builders)[Who can fix this](https://directindex.org/providers)[For agencies](https://directindex.org/agency)

#### For agents

[llms.txt](https://directindex.org/llms.txt)[llms-full.txt](https://directindex.org/llms-full.txt)[OpenAPI](https://directindex.org/openapi.json)[MCP server](https://directindex.org/.well-known/mcp/server-card.json)[A2A agent](https://directindex.org/.well-known/agent-card.json)[Direct feeds](https://directindex.org/direct.json)

#### Data

[Open data, CSV and JSON](https://directindex.org/data)[The quarterly edition](https://directindex.org/editions)[City data, JSON and Markdown](https://directindex.org/cities)[Sitemap](https://directindex.org/sitemap.xml)

Business listings from OpenStreetMap contributors, ODbL. Scores under the same licence.

```json
{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://directindex.org/#org","name":"The Direct Index","url":"https://directindex.org/","logo":"https://directindex.org/favicon.svg","founder":{"@type":"Person","name":"Antonio Curado"},"description":"Independent measurement of whether AI agents can find, read and act on a business's own website."},{"@type":"WebSite","@id":"https://directindex.org/#site","url":"https://directindex.org/","name":"The Direct Index","publisher":{"@id":"https://directindex.org/#org"},"inLanguage":"en","potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://directindex.org/scan?url={url}"},"query-input":"required name=url"}},{"@type":"WebAPI","name":"The Direct Index API","url":"https://directindex.org/openapi.json","documentation":"https://directindex.org/llms-full.txt","provider":{"@id":"https://directindex.org/#org"}}]}
```